A 96-well formatted method for exon and exon/intron boundary full sequencing of the CFTR gene

被引:31
作者
Lucarelli, Marco
Narzi, Lorena
Piergentili, Rita
Ferraguti, Giampiero
Grandoni, Francesco
Quattrucci, Serena
Strom, Roberto
机构
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy
[2] Univ Roma La Sapienza, Dept Pediat, Reg Cyst Fibrosis Ctr, I-00161 Rome, Italy
关键词
CFTR; cystic fibrosis; extended sequencing; high-sensitivity mutational analysis;
D O I
10.1016/j.ab.2006.03.022
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Full genotypic characterization of subjects affected by cystic fibrosis (CF) is essential for the definition of the genotype-phenotype correlation as well as for the enhancement of the diagnostic and prognostic value of the genetic investigation. High-sensitivity diagnostic methods, capable of full scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, are needed to enhance the significance of these genetic assays. A method for extensive sequencing of the CFTR gene was optimized. This method was applied to subjects clinically positive for CF and to controls from the general population of central Italy as well as to a single subject heterozygous for a mild mutation and with an uncertain diagnosis. Some points that are crucial for the optimization of the method emerged: a 96-well format, primer project and purification, and amplicon purification. The optimized method displayed a high degree of diagnostic sensitivity; we identified a subset of 13 CFTR mutations that greatly enhanced the diagnostic sensitivity of common methods of mutational analysis. A novel G1244R disease causing mutation, leading to a CF phenotype with pancreatic sufficiency but early onset of pulmonary involvement, was detected in the subject with an uncertain diagnosis. Some discrepancies between our results and previously published CFTR sequence were found. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:226 / 235
页数:10
相关论文
共 39 条
  • [1] Acton J D, 2001, Paediatr Respir Rev, V2, P332, DOI 10.1053/prrv.2001.0168
  • [2] The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C→T mutation
    Chiba-Falek, O
    Kerem, E
    Shoshani, T
    Aviram, M
    Augarten, A
    Bentur, L
    Tal, A
    Tullis, E
    Rahat, A
    Kerem, B
    [J]. GENOMICS, 1998, 53 (03) : 276 - 283
  • [3] VARIABLE DELETION OF EXON-9 CODING SEQUENCES IN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE MESSENGER-RNA TRANSCRIPTS IN NORMAL BRONCHIAL EPITHELIUM
    CHU, CS
    TRAPNELL, BC
    MURTAGH, JJ
    MOSS, J
    DALEMANS, W
    JALLAT, S
    MERCENIER, A
    PAVIRANI, A
    LECOCQ, JP
    CUTTING, GR
    GUGGINO, WB
    CRYSTAL, RG
    [J]. EMBO JOURNAL, 1991, 10 (06) : 1355 - 1363
  • [4] A RAPID, EFFICIENT, AND SENSITIVE ASSAY FOR SIMULTANEOUS DETECTION OF MULTIPLE CYSTIC-FIBROSIS MUTATIONS
    COSTES, B
    FANEN, P
    GOOSSENS, M
    GHANEM, N
    [J]. HUMAN MUTATION, 1993, 2 (03) : 185 - 191
  • [5] D'Apice Maria Rosaria, 2004, BMC Med Genet, V5, P8, DOI 10.1186/1471-2350-5-8
  • [6] SENSITIVE NEW SUBSTRATE FOR CHYMOTRYPSIN
    DELMAR, EG
    LARGMAN, C
    BRODRICK, JW
    GEOKAS, MC
    [J]. ANALYTICAL BIOCHEMISTRY, 1979, 99 (02) : 316 - 320
  • [7] DEVOTO M, 1991, AM J HUM GENET, V48, P1127
  • [8] Modifier genes and variation in cystic fibrosis
    Drumm, ML
    [J]. RESPIRATORY RESEARCH, 2001, 2 (03) : 125 - 128
  • [9] Complexity in a monogenic disease
    Estivill, X
    [J]. NATURE GENETICS, 1996, 12 (04) : 348 - 350
  • [10] MOLECULAR CHARACTERIZATION OF CYSTIC-FIBROSIS - 16 NOVEL MUTATIONS IDENTIFIED BY ANALYSIS OF THE WHOLE CYSTIC-FIBROSIS CONDUCTANCE TRANSMEMBRANE REGULATOR (CFTR) CODING REGIONS AND SPLICE SITE JUNCTIONS
    FANEN, P
    GHANEM, N
    VIDAUD, M
    BESMOND, C
    MARTIN, J
    COSTES, B
    PLASSA, F
    GOOSSENS, M
    [J]. GENOMICS, 1992, 13 (03) : 770 - 776